AI
SCLN

Atria Investments’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Atria Investments’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,490
Closed -$157K – 504
2015
Q4 		$157K Buy
+19,490
New +$163K 0.02% 384

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atria Investments's SCLN Position: Q1 2016 in Review

Atria Investments sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2016, closing a stake of 19,490 shares — an estimated $157K sold.

Atria Investments first reported a position in SCLN in Q4 2015 and held it in 1 quarter. The position peaked at $157K in Q4 2015. 142 funds tracked by Wall St. Rank hold SCLN as of Q1 2016.

  • Atria Investments reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Atria Investments sold 19,490 Sciclone Pharmaceuticals Inc shares in Q1 2016, an estimated $157K.
  • Atria Investments first reported a position in Sciclone Pharmaceuticals Inc in Q4 2015 and held it in 1 quarter.
  • Atria Investments's Sciclone Pharmaceuticals Inc position peaked at $157K in Q4 2015.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2016.

Based on Atria Investments's 13F filing for Q1 2016, filed 19 Apr 2016.